Moderna, Inc. (NASDAQ:MRNA) has announced updates demonstrating substantial R&D investment and progress in the UK, two years ...

Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) gapped down before the market opened on Wednesday after The Goldman Sachs Group downgraded the stock from a buy rating to a neutral rating. The ...

Hungarys National Centre for Public Health and Pharmacy (NNGYK) is purchasing COVID-19 vaccines for adults and children from ...

A live webcast of both the presentation and the question-and-answer session will be available under "Events and Presentations" in the investor section of Moderna's website at investors.modernatx.com.

and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC's website at www.sec.gov. Except as required by law, Moderna disclaims ...

As we move forward, the BMC remains dedicated to its mission of elevating industry-wide excellence in biospecimen management, raising the bar for data integrity and quality, enabling the future of ...

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.